title: Folly of FDA-approval studies for bone morphogenetic protein.
authors: Department of Orthopaedics, Dartmouth Medical School, Dartmouth Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH 03756, USA. mirza@dartmouth.edu
authors: Sohail K
authors: SK
authors: Mirza
mesh_terms: D055396:Bone Morphogenetic Protein 2 / Q000009:adverse effects*; D002986:Clinical Trials as Topic / Q000592:standards*; D016265:Conflict of Interest; D006801:Humans; D011994:Recombinant Proteins / Q000009:adverse effects; D012107:Research Design / Q000592:standards*; D013123:Spinal Fusion / Q000379:methods*; D016212:Transforming Growth Factor beta / Q000009:adverse effects*
chemical_list: D055396:Bone Morphogenetic Protein 2; D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta; C499469:recombinant human bone morphogenetic protein-2